Today, Robert McWhirter and Paul Harris, CFA commented about whether IPL-T, CVE-T, BAC-N, V-N, NVO-N, META-Q, BCS-N, C-N, BAC-N, NFLX-Q, JNJ-N, BABA-N, GS-N, TSLA-Q, MFC-T, CVS-N, CNR-T, FSV-T, CP-T, XBC-T, ARE-T, LG-X, ARX-T, ALA-T, BNS-T, L-T, MRU-T, ZMS-X, VET-T, PLI-T, EPIC-T, BTO-T, OSB-T, MRE-T, AVO-T, MFC-T, MDX-X, VQS-X, IPL-T, ENB-T, BYL-T, LTV-X, CHE.UN-T, CNQ-T are stocks to buy or sell.
ALA-T vs. ARX-T. ALA-T is going through a reorganization. It complicates his model. The trailing PE is 19 times and it is cash flow positive. The yield is very high at 10.2% with payout at 60%. The ROE is okay at 6%. He would wait until the financing of the spin out is complete and the market should be more comfortable. He does not follow ARX-T.
ALA-T vs. ARX-T. ALA-T is going through a reorganization. It complicates his model. The trailing PE is 19 times and it is cash flow positive. The yield is very high at 10.2% with payout at 60%. The ROE is okay at 6%. He would wait until the financing of the spin out is complete and the market should be more comfortable. He does not follow ARX-T.
It is a company that invests in cannabis opportunities. The most recent is in Australia where it is one of the few companies that is licensed there. They also announced a deal in Jamaica where production is coming on line. It is a reasonably diverse way to participate in the space, but he thinks there are better opportunities in the near term.
With this current pullback, these are days investors long for because you can invest. You can buy companies cheaper. Interest rates are rising because the economy is growing. The market is adjusting to this. Now is an opportunity. If you have a long-term perspective, you can pick up companies you really like. There may be more volatility until rates settle. Could go sideways. There's also the China trade slowing with difficult numbers in Europe, not to mention the US midterms in a month. Volatility can hurt you, but also be your friend if you believe in investing in the next 20 years (i.e. your RRSP). US companies will continue to do well. Maybe there are a few more days of down markets. It's healthy to see a correction. In the next two weeks, a lot of earnings are coming out. Look out for projections of the next several quarters, like the impact of oil or wages. A great opportunity now.
Mainly in property management. Likes that they're capital-light and low capex. Can generate enough cash flow to grow. Acquire a lot of smaller companies in their sector. 25x forward earnings so not cheap, but they execute well. Managers own 20% of shares. (0.7% dividend, Analysts' price target: $108.49)
The key is their ability to take a bag of plasma and extract a bunch of proteins. They can sell as much as they can produce. The market is concerned about their spending in R&D. It appears to be a long way away from payday.